Comparison of Different Vascular Closure Device in TAVI

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

Also called NCT05491070

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 260 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05491070
Other papers using this trial's data
  • Dual ProGlide vs ProGlide and Angio-Seal for Femoral Access Hemostasis After Transcatheter Aortic Valve Replacement: A Randomised Comparative Trial The Canadian journal of cardiology, 2025-01 DOI, PubMed 39245341 PubMed links an erratum for this paper. Erratum: PMID 41866133

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05491070. Randomized; no masking; primary purpose treatment. Start 2018-03-20 (actual); primary completion 2023-04-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Different Vascular Closure Device in TAVI
Condition
Aortic Valve Stenosis
Condition
Transcatheter Aortic Valve Implantation
Intervention (Device)
Vascular closure device (Angio-Seal, Progilde)
Lead sponsor
National Taiwan University Hospital (class: other)

Record details

Record id
cardio:ct-nct05491070
Content hash
d8403d62af6d15786cc31d6d03fb49a27b91a253f21a3ff2dbaf345e57c31744